Avoid common mistakes on your manuscript.
Correction to: Journal of Endocrinological Investigation https://doi.org/10.1007/s40618-020-01491-3
The article “Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer” written by A. Matrone, A. Prete, A. Nervo, A. Ragni, L. Agate, E. Molinaro, C. Giani, L. Valerio, E. Minaldi, A. Piovesan and R. Elise was originally published online on the publisher’s internet portal on 17th February 2021 with Open Access under a Creative Commons Attribution (CC BY) license 4.0 With the authors' decision to cancel Open Access the copyright of the article changed on 28th April 2021 to © Italian Society of Endocrinology (SIE) 2021 with all rights reserved.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matrone, A., Prete, A., Nervo, A. et al. Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. J Endocrinol Invest 44, 2859 (2021). https://doi.org/10.1007/s40618-021-01592-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-021-01592-7